Lessons from the Eye: Stem Cell Therapies Advancing Regenerative Medicine on April 27, 2026 Clinical Trials Disorder of eye Injury of cornea Macular degeneration Regenerative Medicine Retinitis Pigmentosa Stem Cell Therapy +
FDA Policy on RMAT Designations for Therapies on Clinical Hold Remains Unchanged on March 19, 2026 gene therapy Identifier Regenerative Medicine regulatory policy RMAT Study on Hold United States Food and Drug Administration +
Pelage Pharmaceuticals Raises $120M to Advance Hair Loss Regenerative Therapy to Phase 3 Trials on October 15, 2025 Alopecia Androgenetic Alopecia Pelage Phase 3 clinical trial PP405 Regenerative Medicine Series B financing Stem Cell Therapy +
Pfizer Veteran Suneet Varma Named CEO of Phase 3-Ready Biotech Startup Intent Biologics on September 09, 2025 Appointments biotech startup CEO Clinical Trials Immunology Inflammation Intent Biologics Pfizer vet Phase 3 Regenerative Medicine Suneet Varma +
Forging the Future of Cell Therapy: Bayer and BlueRock's Unique Journey on June 06, 2025 Bayer bemdaneprocel biotech partnerships BlueRock Therapeutics Cell Therapy Identifier Parkinson 's disease Phase 3 trials Regenerative Medicine RMAT +
Forging the Future of Cell Therapy: Bayer and BlueRock's Unique Journey on June 05, 2025 Bayer bemdaneprocel biotech partnerships BlueRock Therapeutics Cell Therapy Identifier Parkinson 's disease Phase 3 trials Regenerative Medicine RMAT +